\-\ Texto\\:\\ \ \(0\)\
\-\ generalized\\ decreased\\ breath\\ sounds\ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ the\\ images\\ suggest\\ an\\ progressive\\ interstital\\ lung\\ disease\\ characterized\\ by\\ nodules\\ that\\ evolve\\ to\\ become\\ cystic\\ and\\ clustered\\.\\ \\ the\\ air\\-filled\\ cysts\\ have\\ thin\\ walls\\ and\\ the\\ disease\\ is\\ progressing\\ to\\ end\\ stage\\ fibrosis\\.\ \(0\)\
\-\ pulmonary\\ langerhans\\ cell\\ histiocytosis\ \(1\)\
\-\ pulmonary\\ langerhans\\ cell\\ histiocystosis\ \(0\)\
\-\ lymphangiomyomatosis\ \(2\)\
\-\ campbell\\ williams\\ syndrome\ \(0\)\
\-\ 46\\ y\\.o\\.\\ woman\\ with\\ a\\ history\\ of\\ hypothyroidism\\,\\ diabetes\\ insipidus\\,\\ and\\ biliary\\ obstruction\\.\\ \\ she\\ presents\\ now\\ with\\ increasing\\ shortness\\ of\\ breath\\ and\\ cough\\.\\ \\ she\\ is\\ a\\ smoker\\.\ \(0\)\
\-\ langerhans\\ cells\\,\\ which\\ were\\ originally\\ discovered\\ in\\ squamous\\ epithelium\\,\\ are\\ part\\ of\\ the\\ widespread\\ system\\ of\\ dendritic\\ cells\\.\\ \\ these\\ cells\\,\\ which\\ arise\\ from\\ cd34\\+\\ progenitors\\,\\ are\\ specialized\\ and\\ efficient\\ antigen\\-presenting\\ cells\\ for\\ t\\-cell\\-mediated\\ immunity\\.\\ in\\ this\\ disease\\,\\ however\\,\\ the\\ major\\ associated\\ cells\\ are\\ not\\ t\\ cells\\,\\ but\\ mature\\ eosinophils\\:\\ hence\\ the\\ original\\ name\\ eosinophilic\\ granuloma\\.\ \(0\)\
\-\ langerhans\\ cell\\ histiocystosis\\ occurs\\ most\\ commonly\\ in\\ young\\ children\\ \\(under\\ 6\\ years\\)\\ and\\ usually\\ is\\ characterized\\ by\\ agressive\\ lytic\\ bone\\ lesions\\.\\ \\ in\\ the\\ disseminated\\ form\\,\\ the\\ classic\\ triad\\ is\\ of\\ lytic\\ bone\\ lesions\\,\\ diabetes\\ insipidus\\,\\ and\\ exophthalmos\\.\\ \\ the\\ liver\\ and\\ spleen\\ are\\ often\\ enlarged\\ due\\ to\\ involvement\\.\\ \\ the\\ outdated\\ term\\ histiocytosis\\ x\\ was\\ meant\\ to\\ cover\\ a\\ spectrum\\ of\\ three\\ diseases\\-\\-eosinophilic\\ granuloma\\,\\ hand\\-schuller\\-christian\\ disease\\ \\(hsc\\)\\,\\ and\\ letterer\\-siwe\\ disease\\ \\(ls\\)\\.\ \(0\)\
\-\ pulmonary\\ langerhans\\ cell\\ histiocytosis\\ commonly\\ occurs\\ in\\ young\\ adults\\ and\\ is\\ a\\ terrible\\ progressive\\ disease\\ with\\ the\\ deterioration\\ of\\ lung\\ function\\ despite\\ corticosteroid\\ and\\ d\\-penicillamine\\ treatment\\.\\ \\ most\\ patients\\ are\\ cigarette\\ smokers\\ \\(90\\%\\)\\ and\\ complain\\ of\\ cough\\ \\(50\\%\\)\\,\\ which\\ may\\ be\\ accompanied\\ by\\ exertional\\ dyspnea\\ \\(35\\%\\)\\.\\ the\\ onset\\ of\\ dyspnea\\ is\\ acute\\ in\\ those\\ patients\\ with\\ pneumothorax\\ \\(10\\-20\\%\\)\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ langerhans\\:\\ 0\\.3109508184595968\ \(0\)\
\-\ cells\\:\\ 0\\.2739263137788262\ \(0\)\
\-\ histiocystosis\\:\\ 0\\.18109662469305018\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.1782905245542253\ \(0\)\
\-\ cell\\:\\ 0\\.16948014579735238\ \(0\)\
\-\ insipidus\\:\\ 0\\.16349402946008737\ \(0\)\
\-\ disease\\:\\ 0\\.14923639434447708\ \(0\)\
\-\ and\\:\\ 0\\.14692941234221998\ \(0\)\
\-\ the\\:\\ 0\\.14187988739429802\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.1153631870771236\ \(0\)\
\-\ are\\:\\ 0\\.1124210278074101\ \(0\)\
\-\ characterized\\:\\ 0\\.10888074750549256\ \(0\)\
\-\ pulmonary\\:\\ 0\\.10835416979900153\ \(0\)\
\-\ diabetes\\:\\ 0\\.10824795811047964\ \(0\)\
\-\ granuloma\\:\\ 0\\.10723434347579634\ \(0\)\
\-\ of\\:\\ 0\\.10436174419202222\ \(0\)\
\-\ dyspnea\\:\\ 0\\.10428782414788532\ \(0\)\
\-\ lytic\\:\\ 0\\.09982442901546233\ \(0\)\
\-\ young\\:\\ 0\\.09771883307839749\ \(0\)\
\-\ is\\:\\ 0\\.097362694951829\ \(0\)\
\-\ progenitors\\:\\ 0\\.09476007689403375\ \(0\)\
\-\ outdated\\:\\ 0\\.09476007689403375\ \(0\)\
\-\ hsc\\:\\ 0\\.09476007689403375\ \(0\)\
\-\ occurs\\:\\ 0\\.09343644084384226\ \(0\)\
\-\ progressive\\:\\ 0\\.09076441752409407\ \(0\)\
\-\ efficient\\:\\ 0\\.09054831234652509\ \(0\)\
\-\ cough\\:\\ 0\\.08847728575358906\ \(0\)\
\-\ in\\:\\ 0\\.0884428621600341\ \(0\)\
\-\ commonly\\:\\ 0\\.08769026062076136\ \(0\)\
\-\ lymphangiomyomatosis\\:\\ 0\\.08756001784355394\ \(0\)\
\-\ immunity\\:\\ 0\\.08756001784355394\ \(0\)\
\-\ meant\\:\\ 0\\.08756001784355394\ \(0\)\
\-\ ls\\:\\ 0\\.08756001784355394\ \(0\)\
\-\ breath\\:\\ 0\\.08685763636889446\ \(0\)\
\-\ interstital\\:\\ 0\\.08524211655035649\ \(0\)\
\-\ dendritic\\:\\ 0\\.08524211655035649\ \(0\)\
\-\ specialized\\:\\ 0\\.08524211655035649\ \(0\)\
\-\ terrible\\:\\ 0\\.0833482532960453\ \(0\)\
\-\ agressive\\:\\ 0\\.08174701473004369\ \(0\)\
\-\ which\\:\\ 0\\.08083017671404569\ \(0\)\
\-\ evolve\\:\\ 0\\.07913648874853664\ \(0\)\
\-\ clustered\\:\\ 0\\.07913648874853664\ \(0\)\
\-\ campbell\\:\\ 0\\.07804205749987668\ \(0\)\
\-\ cover\\:\\ 0\\.07804205749987668\ \(0\)\
\-\ cigarette\\:\\ 0\\.0770520240092281\ \(0\)\
\-\ smokers\\:\\ 0\\.0770520240092281\ \(0\)\
\-\ exertional\\:\\ 0\\.0761481942455655\ \(0\)\
\-\ by\\:\\ 0\\.075488079836057\ \(0\)\
\-\ exophthalmos\\:\\ 0\\.07454695567956389\ \(0\)\
\-\ eosinophils\\:\\ 0\\.07315989974259436\ \(0\)\
\-\ lung\\:\\ 0\\.07208980992587322\ \(0\)\
\-\ name\\:\\ 0\\.07137480700556191\ \(0\)\
\-\ deterioration\\:\\ 0\\.07084199844939688\ \(0\)\
\-\ she\\:\\ 0\\.07054501225340742\ \(0\)\
\-\ triad\\:\\ 0\\.0698519649587483\ \(0\)\
\-\ widespread\\:\\ 0\\.06939022274239916\ \(0\)\
\-\ progressing\\:\\ 0\\.06852409715619942\ \(0\)\
\-\ epithelium\\:\\ 0\\.06811669241067707\ \(0\)\
\-\ hence\\:\\ 0\\.06811669241067707\ \(0\)\
\-\ lesions\\:\\ 0\\.06806051117241116\ \(0\)\
\-\ corticosteroid\\:\\ 0\\.06698238591348642\ \(0\)\
\-\ patients\\:\\ 0\\.06666725319229547\ \(0\)\
\-\ complain\\:\\ 0\\.06564020041123965\ \(0\)\
\-\ accompanied\\:\\ 0\\.06473637064757705\ \(0\)\
\-\ bone\\:\\ 0\\.06466167978793864\ \(0\)\
\-\ disseminated\\:\\ 0\\.06417474795508211\ \(0\)\
\-\ mature\\:\\ 0\\.06338544514524694\ \(0\)\
\-\ original\\:\\ 0\\.06289070928712118\ \(0\)\
\-\ williams\\:\\ 0\\.06219016369191936\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.0617480761446059\ \(0\)\
\-\ most\\:\\ 0\\.06167517213844445\ \(0\)\
\-\ smoker\\:\\ 0\\.06071877043520743\ \(0\)\
\-\ originally\\:\\ 0\\.06033400461507104\ \(0\)\
\-\ spectrum\\:\\ 0\\.0601468375786043\ \(0\)\
\-\ to\\:\\ 0\\.05925355397664411\ \(0\)\
\-\ spleen\\:\\ 0\\.0576815935385618\ \(0\)\
\-\ generalized\\:\\ 0\\.0565725423163607\ \(0\)\
\-\ walls\\:\\ 0\\.05557056231549797\ \(0\)\
\-\ adults\\:\\ 0\\.05533447284638934\ \(0\)\
\-\ biliary\\:\\ 0\\.055103630246687005\ \(0\)\
\-\ 46\\:\\ 0\\.05444037375274628\ \(0\)\
\-\ diseases\\:\\ 0\\.05444037375274628\ \(0\)\
\-\ arise\\:\\ 0\\.05422837681325119\ \(0\)\
\-\ discovered\\:\\ 0\\.05402062009811798\ \(0\)\
\-\ squamous\\:\\ 0\\.0533245470495886\ \(0\)\
\-\ part\\:\\ 0\\.0529467785281245\ \(0\)\
\-\ become\\:\\ 0\\.052582267812526826\ \(0\)\
\-\ end\\:\\ 0\\.05214391207394266\ \(0\)\
\-\ major\\:\\ 0\\.05180607776204235\ \(0\)\
\-\ form\\:\\ 0\\.05180607776204235\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.05164119351457005\ \(0\)\
\-\ despite\\:\\ 0\\.051559722591154974\ \(0\)\
\-\ those\\:\\ 0\\.0507033398440183\ \(0\)\
\-\ fibrosis\\:\\ 0\\.049638843744278446\ \(0\)\
\-\ under\\:\\ 0\\.04904885928812639\ \(0\)\
\-\ children\\:\\ 0\\.048551159809585014\ \(0\)\
\-\ suggest\\:\\ 0\\.04813441379590955\ \(0\)\
\-\ function\\:\\ 0\\.04796080268801643\ \(0\)\
\-\ shortness\\:\\ 0\\.047511543936078336\ \(0\)\
\-\ 35\\:\\ 0\\.047511543936078336\ \(0\)\
\-\ 90\\:\\ 0\\.04734795804364631\ \(0\)\
\-\ stage\\:\\ 0\\.04718690846901134\ \(0\)\
\-\ nodules\\:\\ 0\\.04708091275861066\ \(0\)\
\-\ increasing\\:\\ 0\\.04666742575108987\ \(0\)\
\-\ term\\:\\ 0\\.04646669507027647\ \(0\)\
\-\ with\\:\\ 0\\.046410711248581746\ \(0\)\
\-\ thin\\:\\ 0\\.0461244879991088\ \(0\)\
\-\ sounds\\:\\ 0\\.0457467194776447\ \(0\)\
\-\ system\\:\\ 0\\.045204640515254156\ \(0\)\
\-\ cysts\\:\\ 0\\.04490101795457129\ \(0\)\
\-\ classic\\:\\ 0\\.04431916645434692\ \(0\)\
\-\ involvement\\:\\ 0\\.042886739222056686\ \(0\)\
\-\ obstruction\\:\\ 0\\.041504085696463175\ \(0\)\
\-\ 50\\:\\ 0\\.041381518026773464\ \(0\)\
\-\ liver\\:\\ 0\\.04087616137481875\ \(0\)\
\-\ now\\:\\ 0\\.040675014214310294\ \(0\)\
\-\ enlarged\\:\\ 0\\.0403942541640539\ \(0\)\
\-\ three\\:\\ 0\\.03977592867977161\ \(0\)\
\-\ often\\:\\ 0\\.03866324402453087\ \(0\)\
\-\ onset\\:\\ 0\\.03804868976666093\ \(0\)\
\-\ usually\\:\\ 0\\.037302600703960916\ \(0\)\
\-\ decreased\\:\\ 0\\.036703156161408144\ \(0\)\
\-\ years\\:\\ 0\\.03632192109911887\ \(0\)\
\-\ syndrome\\:\\ 0\\.03572195181662579\ \(0\)\
\-\ cystic\\:\\ 0\\.03568668017157689\ \(0\)\
\-\ however\\:\\ 0\\.03507145166652846\ \(0\)\
\-\ due\\:\\ 0\\.03406032069977385\ \(0\)\
\-\ these\\:\\ 0\\.0334607354634768\ \(0\)\
\-\ acute\\:\\ 0\\.03205415916809355\ \(0\)\
\-\ associated\\:\\ 0\\.03123131174163191\ \(0\)\
\-\ woman\\:\\ 0\\.030859687119019808\ \(0\)\
\-\ were\\:\\ 0\\.030543734922503264\ \(0\)\
\-\ may\\:\\ 0\\.029818491038696927\ \(0\)\
\-\ have\\:\\ 0\\.02960063294009077\ \(0\)\
\-\ but\\:\\ 0\\.029301205258882176\ \(0\)\
\-\ presents\\:\\ 0\\.028504241972627485\ \(0\)\
\-\ treatment\\:\\ 0\\.028225833629305794\ \(0\)\
\-\ images\\:\\ 0\\.027408928971113872\ \(0\)\
\-\ that\\:\\ 0\\.025714022365626008\ \(0\)\
\-\ be\\:\\ 0\\.024036986883672132\ \(0\)\
\-\ from\\:\\ 0\\.02353318445476444\ \(0\)\
\-\ not\\:\\ 0\\.023392077412031184\ \(0\)\
\-\ an\\:\\ 0\\.022658538175052756\ \(0\)\
\-\ history\\:\\ 0\\.02263846572535514\ \(0\)\
\-\ was\\:\\ 0\\.0206506124545958\ \(0\)\
\-\ this\\:\\ 0\\.02036074819401606\ \(0\)\
\-\ for\\:\\ 0\\.01795943856920936\ \(0\)\
